Latest Atopic Dermatitis Video Pearls News
Tralokinumab Controls Moderate-to-Severe AD Over the Long Term
Tralokinumab (Adbry) was approved by the FDA in December 2021 for adult…
Improving Treatment Adherence in Atopic Dermatitis
Management of atopic dermatitis has improved dramatically over the last few years,…
IL-13 Blocker for Eczema Maintains Efficacy at Less-Frequent Dosing
In two phase III trials (ADvocate1 and ADvocate2), adult and adolescent patients…
Transitioning Patients With Atopic Dermatitis From Topical to Systemic Therapy
At the recent 2023 Fall Clinical Dermatology Conference, several encouraging findings on…
